Daiichi Sankyo

Indian merger creates fifth-largest generic drugmaker
Medical Marketing and Media
Mon, 12/8/14 - 11:23 pm
India
M&A
generics
Sun Pharma
Ranbaxy
Daiichi Sankyo
FDA Advisory Panel Gives Tepid Support To New Daiichi Sankyo Drug
Forbes
Fri, 10/31/14 - 02:01 pm
FDA
Daiichi Sankyo
advisory panels
bloodthinners
Savaysa
edoxaban
FDA staff recommends limited use of Daiichi's blood thinner
Yahoo/Reuters
Tue, 10/28/14 - 11:34 am
Daiichi Sankyo
FDA
bloodthinners
edoxaban
atrial fibrillation
Is Ambit Biosciences Getting Enough in Its Buyout?
Yahoo/24-7 Wall St
Mon, 09/29/14 - 01:53 pm
M&A
Ambit Biosciences
Daiichi Sankyo
Daiichi Sankyo to Buy Ambit to Boost Cancer Drug Pipeline
Bloomberg
Mon, 09/29/14 - 07:55 am
Daiichi Sankyo
Ambit Biosciences
M&A
Daiichi Sankyo bets up to $650M on Charleston's pain potential
Fierce Biotech
Thu, 08/7/14 - 09:51 am
Daiichi Sankyo
Charleston Laboratories
painkillers
CL-108
hydrocodone
10 big brands keep pumping out big bucks, with a little help from price hikes
Fierce Pharma Marketing
Wed, 05/7/14 - 03:42 pm
Xyrem
Jazz Pharmaceuticals
Humulin
Eli Lilly
Premarin
Mylan
Lunesta
Sunovion
Benicar
Daiichi Sankyo
Lantus
Sanofi
Viagra
Pfizer
Gleevec
Novartis
Copaxone
Teva Pharmaceuticals
EpiPen
drug pricing
Daiichi Sankyo pledges bold action on Ranbaxy production problems
Reuters
Fri, 01/31/14 - 08:16 am
drug manufacturing
Daiichi Sankyo
Ranbaxy
Large Study Finds Favorable Risk-Benefit Profile For The New Anticoagulants
Forbes
Thu, 12/5/13 - 06:45 pm
bloodthinners
Pradaxa
Boehringer Ingelheim
Xarelto
JNJ
Eliquis
Pfizer
Bristol-Myers Squibb
edoxaban
Daiichi Sankyo
Pfizer And GlaxoSmithKline: Aiming For Melanoma Cure Supremacy
Seeking Alpha
Thu, 12/5/13 - 06:43 pm
Pfizer
GSK
melanoma
Bristol-Myers Squibb
AstraZeneca
Daiichi Sankyo
Novartis
Yervoy
palbociclib
Mekinist
Zelboraf
New Anticoagulant From Daiichi Sankyo Works Well In AF Patients
Forbes
Tue, 11/19/13 - 12:35 pm
Daiichi Sankyo
edoxaban
bloodthinners
Warfarin
atrial fibrillation
Can The First Malaria Vaccine Drive GlaxoSmithKline's Growth?
Seeking Alpha
Wed, 10/16/13 - 08:35 am
GSK
vaccines
malaria
Agenus
Daiichi Sankyo
RTS,S
JNJ
Data on ArQule's Tivantinib
Yahoo/Zacks
Sat, 10/5/13 - 09:18 am
Arqule
tivantinib
Daiichi Sankyo
lung cancer
non-small cell lung cancer
ArQule up on hope for lung cancer drug revival
Reuters
Fri, 09/27/13 - 11:51 am
Arqule
tivantinib
Daiichi Sankyo
lung cancer
Daiichi Sankyo’s New Blood Thinner Matched Warfarin in Study
Bloomberg
Tue, 09/3/13 - 09:27 am
bloodthinners
Daiichi Sankyo
Warfarin
edoxaban
Astellas forecasts big sales growth as prostate drug catches hold
Fierce Pharma
Mon, 05/13/13 - 12:27 pm
Astellas
Xtandi
Daiichi Sankyo
Japan
Takeda
prostate cancer
Encouraging Phase 1 data with lead compound, ARQ 092, to be presented at AACR
Yahoo
Mon, 04/1/13 - 10:58 am
ARQ092
Daiichi Sankyo
Arqule
akt protein inhibitor
cancer
Latest Tivantinib Failure Hits ArQule Despite Its Irrelevance
Seeking Alpha
Tue, 01/15/13 - 11:39 am
tivantinib
Arqule
colorectal cancer
Daiichi Sankyo
ArQule: An Inexpensive And Well-Financed Oncology Opportunity
Seeking Alpha
Thu, 12/13/12 - 04:29 pm
Arqule
Daiichi Sankyo
ARQ-087
ArQule stock plunges as lung cancer study shelved
Yahoo/AP
Tue, 10/2/12 - 11:25 am
Arqule
lung cancer
Daiichi Sankyo
tivantinib
non-small cell lung cancer

Pages